Avenue Biosciences
From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
$5.7M ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 18, 2023 (3 years old)
Funding rounds
- Round · $5.7MSource: fundraisingfox.com
- Website created
Founders and team
TA
Tero-Pekka Alastalo CEO, co-founderLinkedIn · source: avenuebiosciences.comKR
Katja Rosti COO, co-foundersource: avenuebiosciences.com
Investors
Companies like Avenue Biosciences
CCellaresSeries B+ · Jul 2026
PPolysense$10.7M Seed · Jul 2026
FForge Biologics$90M Series B+ · Sep 2022
RRevamp MedicalSeries A · May 2023HHuasaiboman Medical Cell Biology$29.97M Series B+ · Nov 2026
IImmutrin$86.45M Series A · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/avenue-biosciences (get a free API key).